Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
6.19
-0.27 (-4.18%)
At close: May 14, 2025, 4:00 PM
6.01
-0.18 (-2.91%)
After-hours: May 14, 2025, 7:21 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $629.80 million as of May 14, 2025. Its market cap has increased by 221.64% in one year.
Market Cap
629.80M
Enterprise Value
527.50M
1-Year Change
221.64%
Ranking
Category
Stock Price
$6.19
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $629.80M, an increase of 641.04%. That is a compound annual growth rate of 39.46%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.08B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |